fbpx

We nurture and develop
multidisciplinary startup teams
that harness emerging tech
to create businesses with
global impact.

Discover

Join the best in class programs designed to empower you with innovation best practices and entrepreneurial frameworks.

Learn More

Build

Access one-on-one coaching and results-driven programming to secure customers, funding, and global expansion.

Learn More

Join

Get involved in the innovation ecosystem to learn about entrepreneurship and emerging technologies. Meet like-minded peers and industry leaders.

Learn More

D3 Bio

Founders leveraging biomanufacturing and bioengineering looking to accelerate their commercialization potential and contribute to building Canada’s bioeconomy in sectors such as biopharma, agri-food, clean technologies and biomaterials.

D3 Healthcare

Early stage medtech and healthtech startups looking to gain market insights, validate clinical and market needs, accelerate product development, find funding and access international networks.

D3 High Tech

Early stage startups focusing on emerging technologies looking to accelerate their path towards commercialization through coaching, lean entrepreneurship skill development, targeted ecosystem connections and global market expansion support. 

D3 Social

Early stage startups focused on education, health, environment, culture or other social issues with positive impact on the community and the world looking  for support in roadmap development, funding strategy and global market expansion.

We bridge the knowledge,
skills, and resource gap
between building a
product and building a
company.

Our Impact

619
Startups
$20M
Financing Raised
& Sales in 2019
42%
Startups with
Female Founders
82%
Startups with
Immigrant Founders
85%
Startups with
Graduate-Level
Founders
12,000
Community Members

Where To Find Us

Our districts are intertwined networks of physical and digital spaces.

Our Footprint

100+
Startups Exposed to
Global Mindset
30+
Partners
20+
Cities

I had been a scientist all my life. Patents and papers have a major impact only when they become a product, therapy, or tool. I’ve grown tremendously since thanks to the right support to guide me along my entrepreneurial journey.”

Margaret Magdesian, Ph.D., Co-founder of Ananda Devices

Latest News

  • D3’s Gray Oncology Solutions receives $1.25M CAD in funding
    D3's healthcare startup Gray Oncology Solutions draws $1.25 million CAD ($1 million USD) in funding from angel investors.
  • D3’s Whale Seeker publishes first whale detection research study
    Whale Seeker published a research study on medium-sized whale detection using VHR satellite imagery in collaboration with Canadian researchers.
  • Concordia’s Another Fish participates in XPRIZE Feed The Next Billion with D3’s…
    Another Fish is developing an alternative protein for XPRIZE Feed The Next Billion with the support of Concordia University’s SynBioApps…